BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31082639)

  • 1. Structure-based screening and validation of potential dengue virus inhibitors through classical and QM/MM affinity estimation.
    Ahmed M; Kumar A; Hobman TC; Barakat K
    J Mol Graph Model; 2019 Jul; 90():128-143. PubMed ID: 31082639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
    Aarthy M; Singh SK
    Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
    Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
    Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
    Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
    ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
    Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
    J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
    Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
    Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
    Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.
    Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB
    ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
    Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
    J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics.
    Parikesit AA; Kinanty ; Tambunan US
    Pak J Biol Sci; 2013 Dec; 16(24):1836-48. PubMed ID: 24516999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study.
    Shimu MSS; Mahmud S; Tallei TE; Sami SA; Adam AA; Acharjee UK; Paul GK; Emran TB; Zaman S; Uddin MS; Saleh MA; Alshehri S; Ghoneim MM; Alruwali M; Obaidullah AJ; Jui NR; Kim J; Kim B
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein.
    Amir-Hassan A; Lee VS; Baharuddin A; Othman S; Xu Y; Huang M; Yusof R; Rahman NA; Othman R
    J Mol Graph Model; 2017 Jun; 74():273-287. PubMed ID: 28458006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small-molecule dengue virus entry inhibitor.
    Wang QY; Patel SJ; Vangrevelinghe E; Xu HY; Rao R; Jaber D; Schul W; Gu F; Heudi O; Ma NL; Poh MK; Phong WY; Keller TH; Jacoby E; Vasudevan SG
    Antimicrob Agents Chemother; 2009 May; 53(5):1823-31. PubMed ID: 19223625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections.
    Ajmal A; Shahab M; Waqas M; Zheng G; Zulfat M; Bin Jardan YA; Wondmie GF; Bourhia M; Ali I
    Sci Rep; 2024 Jun; 14(1):13130. PubMed ID: 38849372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-dengue virus activity of scytovirin and evaluation of point mutation effects by molecular dynamics and binding free energy calculations.
    Siqueira AS; Jerônimo Lima AR; de Souza RC; Santos AS; da Silva Gonçalves Vianez Júnior JL; Gonçalves EC
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1033-1038. PubMed ID: 28666874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation.
    Anusuya S; Gromiha MM
    J Biomol Struct Dyn; 2017 Oct; 35(13):2895-2909. PubMed ID: 27608509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.